Apr 19 |
Addex to Present at the Swiss Biotech Day 2024
|
Apr 18 |
Addex Therapeutics Ltd (ADXN) Q4 2023 Earnings Call Transcript
|
Apr 18 |
Earnings Scheduled For April 18, 2024
|
Apr 18 |
Addex Therapeutics GAAP EPS of -CHF 0.14, revenue of CHF 1.65M
|
Apr 18 |
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
|
Apr 11 |
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024
|
Apr 9 |
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
|
Apr 4 |
EIGR, ADXN and BROG are among premarket gainers
|
Apr 3 |
Addex stock climbs on launch of new company, Neurosterix
|
Apr 3 |
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders
|